These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 18430098

  • 1. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
    Zenda S, Hironaka S, Boku N, Yamazaki K, Yasui H, Fukutomi A, Yoshino T, Onozawa Y, Nishimura T.
    Dis Esophagus; 2008; 21(3):195-200. PubMed ID: 18430098
    [Abstract] [Full Text] [Related]

  • 2. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
    Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A.
    J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M.
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [Abstract] [Full Text] [Related]

  • 4. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK, Chiu PW, Leung SF, Cheung KY, Chan AC, Au-Yeung AC, Griffith JF, Chung SS, Ng EK.
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [Abstract] [Full Text] [Related]

  • 5. [Concurrent chemoradiotherapy for T4 and/or M1 LYM squamous cell carcinoma of the esophagus].
    Miyata Y, Seki S, Ohtsu A, Kaneko K, Nakamura A.
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1174-9. PubMed ID: 10945013
    [Abstract] [Full Text] [Related]

  • 6. Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.
    Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.
    Clin Transl Oncol; 2006 Jan; 8(1):22-30. PubMed ID: 16632436
    [Abstract] [Full Text] [Related]

  • 7. Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: a phase 2 trial (KDOG 0501-P2).
    Higuchi K, Komori S, Tanabe S, Katada C, Azuma M, Ishiyama H, Sasaki T, Ishido K, Katada N, Hayakawa K, Koizumi W, Kitasato Digestive Disease and Oncology Group.
    Int J Radiat Oncol Biol Phys; 2014 Jul 15; 89(4):872-9. PubMed ID: 24867539
    [Abstract] [Full Text] [Related]

  • 8. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S.
    J Surg Oncol; 2009 Apr 01; 99(5):302-6. PubMed ID: 19170110
    [Abstract] [Full Text] [Related]

  • 9. Impact of chemoradiotherapy-induced anemia on survival in uniformly staged patients with locally advanced squamous cell carcinoma of the esophagus.
    Hofheinz RD, Raab B, Mai S, Wenz F, Willeke F, Emig M, Buchheidt D, Hehlmann R, Hochhaus A.
    Onkologie; 2004 Oct 01; 27(5):462-6. PubMed ID: 15585976
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y, Ochiai T, Matsubara H, Okazumi S, Shiratori T, Shuto K, Aoki T, Miyazaki S, Gunji Y, Uno T, Ito H, Shimada H.
    Dis Esophagus; 2005 Oct 01; 18(6):388-97. PubMed ID: 16336610
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Kumekawa Y, Kaneko K, Ito H, Kurahashi T, Konishi K, Katagiri A, Yamamoto T, Kuwahara M, Kubota Y, Muramoto T, Mizutani Y, Imawari M.
    J Gastroenterol; 2006 May 01; 41(5):425-32. PubMed ID: 16799883
    [Abstract] [Full Text] [Related]

  • 13. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H.
    J Surg Oncol; 2005 Jun 15; 90(4):209-19. PubMed ID: 15906363
    [Abstract] [Full Text] [Related]

  • 14. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy.
    Ishihara R, Yamamoto S, Iishi H, Takeuchi Y, Sugimoto N, Higashino K, Uedo N, Tatsuta M, Yano M, Imai A, Nishiyama K.
    Int J Radiat Oncol Biol Phys; 2010 Jan 01; 76(1):123-9. PubMed ID: 19386426
    [Abstract] [Full Text] [Related]

  • 15. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 16. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M, Yano M, Ishihara R, Yamamoto S, Kawaguchi Y, Tanaka K, Kishi K, Miyashiro I, Fujiwara Y, Shingai T, Noura S, Ohue M, Ohigashi H, Nakamura S, Ishikawa O.
    Ann Surg Oncol; 2012 Jul 01; 19(7):2135-41. PubMed ID: 22302264
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy.
    Zhang HQ, Wang RB, Yan HJ, Zhao W, Zhu KL, Jiang SM, Hu XG, Yu JM.
    Asian Pac J Cancer Prev; 2012 Jul 01; 13(1):199-203. PubMed ID: 22502668
    [Abstract] [Full Text] [Related]

  • 18. Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.
    Ohira M, Kubo N, Masuda G, Yamashita Y, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Hirakawa K.
    Anticancer Res; 2015 Sep 01; 35(9):4897-901. PubMed ID: 26254385
    [Abstract] [Full Text] [Related]

  • 19. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
    Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T, Yoshida S.
    J Clin Oncol; 2003 Jul 15; 21(14):2697-702. PubMed ID: 12860946
    [Abstract] [Full Text] [Related]

  • 20. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, Yagyu R, Nishiwaki M, Fujiwara M, Kojima S, Nakagawa K, Yamamura T.
    Oncol Rep; 2005 Nov 15; 14(5):1177-82. PubMed ID: 16211282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.